PMID- 12540642 OWN - NLM STAT- MEDLINE DCOM- 20030127 LR - 20220409 IS - 1533-4406 (Electronic) IS - 0028-4793 (Linking) VI - 348 IP - 4 DP - 2003 Jan 23 TI - Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. PG - 295-303 AB - BACKGROUND: The influence of left ventricular outflow tract obstruction on the clinical outcome of hypertrophic cardiomyopathy remains unresolved. METHODS: We assessed the effect of outflow tract obstruction on morbidity and mortality in a large cohort of patients with hypertrophic cardiomyopathy who were followed for a mean (+/-SD) of 6.3+/-6.2 years. RESULTS: Of the 1101 consecutive patients, 273 (25 percent) had obstruction of left ventricular outflow under basal (resting) conditions with a peak instantaneous gradient of at least 30 mm Hg. A total of 127 patients (12 percent) died of hypertrophic cardiomyopathy, and 216 surviving patients (20 percent) had severe, disabling symptoms of progressive heart failure (New York Heart Association [NYHA] functional class III or IV). The overall probability of death related to hypertrophic cardiomyopathy was significantly greater among patients with outflow tract obstruction than among those without obstruction (relative risk, 2.0; P=0.001). The risk of progression to NYHA class III or IV or death specifically from heart failure or stroke was also greater among patients with obstruction (relative risk, 4.4; P<0.001), particularly among patients 40 years of age or older (P<0.001). Age-adjusted multivariate analysis confirmed that outflow tract obstruction was independently associated with an increased risk of both death related to hypertrophic cardiomyopathy (relative risk, 1.6; P=0.02) and progression to NYHA class III or IV or death from heart failure or stroke (relative risk, 2.7; P<0.001). The likelihood of severe symptoms and death related to outflow tract obstruction did not increase as the gradient increased above the threshold of 30 mm Hg. CONCLUSIONS: In patients with hypertrophic cardiomyopathy, left ventricular outflow tract obstruction at rest is a strong, independent predictor of progression to severe symptoms of heart failure and of death. CI - Copyright 2003 Massachusetts Medical Society FAU - Maron, Martin S AU - Maron MS AD - Division of Cardiology, Tufts-New England Medical Center, Boston, USA. FAU - Olivotto, Iacopo AU - Olivotto I FAU - Betocchi, Sandro AU - Betocchi S FAU - Casey, Susan A AU - Casey SA FAU - Lesser, John R AU - Lesser JR FAU - Losi, Maria A AU - Losi MA FAU - Cecchi, Franco AU - Cecchi F FAU - Maron, Barry J AU - Maron BJ LA - eng PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't PL - United States TA - N Engl J Med JT - The New England journal of medicine JID - 0255562 SB - IM CIN - N Engl J Med. 2003 May 1;348(18):1815-6; author reply 1815-6. PMID: 12724493 CIN - N Engl J Med. 2003 May 1;348(18):1815-6; author reply 1815-6. PMID: 12728915 CIN - N Engl J Med. 2003 May 1;348(18):1815-6; author reply 1815-6. PMID: 12728916 MH - Adult MH - Cardiomyopathy, Hypertrophic/*complications/mortality MH - Death, Sudden, Cardiac/etiology MH - Disease Progression MH - Female MH - Heart Failure/classification/*etiology/mortality MH - Humans MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Proportional Hazards Models MH - Prospective Studies MH - Risk Factors MH - Stroke/mortality MH - Ultrasonography MH - Ventricular Outflow Obstruction/classification/*complications/diagnostic imaging EDAT- 2003/01/24 04:00 MHDA- 2003/01/28 04:00 CRDT- 2003/01/24 04:00 PHST- 2003/01/24 04:00 [pubmed] PHST- 2003/01/28 04:00 [medline] PHST- 2003/01/24 04:00 [entrez] AID - 348/4/295 [pii] AID - 10.1056/NEJMoa021332 [doi] PST - ppublish SO - N Engl J Med. 2003 Jan 23;348(4):295-303. doi: 10.1056/NEJMoa021332.